Tech Innovator Profile – Recursion Pharmaceuticals, Inc

Pages: 10 Published: April 30, 2020 Report Code: GDDT0334DC

Recursion Pharmaceuticals, Inc. is a biotechnology company. Recursion combines experimental biology and bioinformatics with artificial intelligence (AI) in a parallel system to identify treatments quickly and efficiently for any disease which can be modeled at the cellular level.


The report provides information and insights into Recursion's, including –

– Overview of the company and its product offering

– Detailed insight into its business model, company type and headquarter

– Information on funding

– Biography of top management

Reasons to Buy

– Gain insights into Recursion’s business operations.

– Gain insights into funding and partnerships

– Gain understanding about its technology focus.

Key Players

University of Utah

Takeda Pharmaceutical

Ohio State Innovation Foundation

Winzeler Lab


Bill & Melinda Gates Foundation

Table of Contents

Table of Contents

Company Overview

Technology Focus Area

Product Overview

Partnerships & Funding

Key Employees


Frequently Asked Questions

Enquire Before Buying

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.

How Digital Transition is Reshaping Capital Markets
$1495 | August 12, 2022
3M Company – Enterprise Tech Ecosystem Series
$1495 | August 12, 2022
Marathon Petroleum Corp – Enterprise Tech Ecosystem Series
$1495 | August 12, 2022